Loading...

Fresenius Medical Care AG & Co. KGaA Peer Comparison

Metric Value Ranking
Market Cap $14.3 Billion 2/13 HCA
$84.7B
FMS
$14.3B
THC
$12.0B
UHS
$11.8B
EHC
$9.9B
ENSG
$7.2B
ACHC
$3.8B
SGRY
$3.3B
SEM
$2.4B
ADUS
$2.1B
PNTG
$890.7M
INNV
$457.1M
AIH
$15.8M
Gross Margin 24% 9/13 PNTG
100%
ACHC
96%
HCA
85%
UHS
72%
AIH
47%
EHC
46%
THC
35%
ADUS
33%
FMS
24%
SGRY
23%
INNV
17%
ENSG
15%
SEM
11%
Profit Margin 4% 8/13 THC
13%
EHC
9%
ACHC
8%
HCA
7%
UHS
7%
ADUS
7%
ENSG
7%
FMS
4%
SEM
3%
PNTG
3%
INNV
-2%
SGRY
-4%
AIH
-8%
EBITDA margin 18% 5/13 SEM
88%
ACHC
20%
HCA
19%
EHC
19%
FMS
18%
UHS
13%
ENSG
11%
ADUS
10%
THC
9%
PNTG
3%
INNV
1%
AIH
-2%
SGRY
-5%
Quarterly Revenue $5.2 Billion 2/13 HCA
$17.5B
FMS
$5.2B
THC
$5.1B
UHS
$4.0B
SEM
$1.8B
EHC
$1.4B
ENSG
$1.1B
ACHC
$815.6M
SGRY
$770.4M
ADUS
$289.8M
INNV
$205.1M
PNTG
$180.7M
AIH
$41.9M
Quarterly Earnings $234.1 Million 4/13 HCA
$1.3B
THC
$681.0M
UHS
$258.7M
FMS
$234.1M
EHC
$120.9M
ENSG
$78.4M
ACHC
$68.1M
SEM
$55.6M
ADUS
$20.2M
PNTG
$6.2M
AIH
-$3.2M
INNV
-$4.9M
SGRY
-$31.7M
Quarterly Free Cash Flow $1.2 Million 2/13 HCA
$2.3B
FMS
$1.2B
THC
$839.0M
SEM
$289.0M
ENSG
$89.0M
UHS
$81.9M
ADUS
$46.6M
SGRY
$45.0M
PNTG
$18.2M
INNV
-$9.7M
ACHC
-$27.1M
EHC
-$0
AIH
-$0
Trailing 4 Quarters Revenue $21.1 Billion 2/13 HCA
$69.6B
FMS
$21.1B
THC
$21.0B
UHS
$15.4B
SEM
$7.0B
EHC
$5.4B
ENSG
$4.1B
ACHC
$3.1B
SGRY
$3.0B
ADUS
$1.1B
INNV
$786.5M
PNTG
$652.3M
AIH
$157.3M
Trailing 4 Quarters Earnings $724.1 Million 4/13 HCA
$17.5B
FMS
$5.2B
THC
$5.1B
UHS
$4.0B
SEM
$1.8B
EHC
$1.4B
ENSG
$1.1B
ACHC
$815.6M
SGRY
$770.4M
ADUS
$289.8M
INNV
$205.1M
PNTG
$180.7M
AIH
$41.9M
Quarterly Earnings Growth 153% 2/13 THC
574%
FMS
153%
ACHC
131%
UHS
55%
INNV
52%
AIH
42%
PNTG
42%
EHC
38%
ADUS
31%
ENSG
23%
HCA
18%
SEM
15%
SGRY
-188%
Annual Earnings Growth 30% 8/13 ACHC
34630%
THC
726%
AIH
78%
PNTG
66%
INNV
64%
UHS
51%
EHC
33%
FMS
30%
HCA
27%
ADUS
23%
SEM
-3%
ENSG
-6%
SGRY
-101%
Quarterly Revenue Growth -4% 12/13 PNTG
29%
ENSG
15%
SGRY
14%
EHC
13%
INNV
12%
UHS
11%
ACHC
9%
HCA
8%
ADUS
7%
SEM
6%
THC
1%
FMS
-4%
AIH
-64%
Annual Revenue Growth -1% 13/13 AIH
5986%
PNTG
21%
SGRY
12%
EHC
10%
ENSG
10%
INNV
10%
HCA
9%
UHS
9%
ADUS
8%
ACHC
6%
SEM
4%
THC
3%
FMS
-1%
Cash On Hand $1.5 Billion 3/13 THC
$4.1B
HCA
$2.9B
FMS
$1.5B
ENSG
$532.1M
ADUS
$222.9M
SGRY
$221.8M
SEM
$191.5M
UHS
$106.1M
EHC
$85.4M
ACHC
$82.1M
INNV
$39.0M
AIH
$14.4M
PNTG
$4.5M
Short Term Debt $1.8 Billion 2/13 HCA
$4.7B
FMS
$1.8B
SEM
$292.6M
EHC
$164.9M
UHS
$111.2M
SGRY
$97.3M
THC
$95.0M
ACHC
$71.7M
INNV
$23.1M
AIH
$21.5M
PNTG
$19.1M
ADUS
$11.2M
ENSG
$4.1M
Long Term Debt $10.5 Billion 3/13 HCA
$38.3B
THC
$12.8B
FMS
$10.5B
UHS
$5.0B
SEM
$4.3B
SGRY
$3.4B
ACHC
$1.8B
PNTG
$357.8M
EHC
$189.7M
ENSG
$142.6M
INNV
$96.5M
ADUS
$38.6M
AIH
$26.6M
PE 19.71 5/13 PNTG
42.11
ENSG
30.20
ADUS
28.13
EHC
21.67
FMS
19.71
HCA
14.28
ACHC
13.66
UHS
11.52
SEM
8.65
THC
3.09
SGRY
-1.00
AIH
-1.00
INNV
-1.00
PS 0.61 9/13 EHC
1.84
ADUS
1.83
ENSG
1.78
PNTG
1.37
ACHC
1.23
HCA
1.22
SGRY
1.10
UHS
0.77
FMS
0.61
INNV
0.58
THC
0.57
AIH
0.44
SEM
0.34
PB 0.88 13/13 HCA
107.73
PNTG
4.76
ENSG
4.14
EHC
3.47
ADUS
2.19
AIH
2.04
UHS
1.77
SGRY
1.73
INNV
1.57
THC
1.49
ACHC
1.22
SEM
1.03
FMS
0.88
PC 9.47 10/13 PNTG
199.52
EHC
115.65
UHS
111.46
ACHC
46.68
HCA
29.32
SGRY
14.76
ENSG
13.62
SEM
12.33
INNV
11.72
FMS
9.47
ADUS
9.30
THC
2.93
AIH
1.10
Liabilities to Equity 1.30 8/13 AIH
10.78
THC
5.55
SEM
2.98
SGRY
2.97
PNTG
2.71
ENSG
1.65
EHC
1.32
FMS
1.30
UHS
1.15
INNV
0.91
ACHC
0.90
ADUS
0.22
HCA
0.00
ROA 0.02 10/13 THC
13%
HCA
10%
UHS
7%
EHC
7%
ADUS
6%
ACHC
5%
ENSG
5%
SEM
3%
PNTG
3%
FMS
2%
SGRY
0%
AIH
-2%
INNV
-3%
ROE 0.05 9/13 THC
101%
EHC
16%
UHS
15%
SEM
14%
ENSG
14%
PNTG
12%
ACHC
9%
ADUS
8%
FMS
5%
SGRY
0%
INNV
-6%
AIH
-18%
HCA
-272%
Current Ratio 1.83 5/13 ADUS
5.62
INNV
2.23
ACHC
2.15
UHS
1.87
FMS
1.83
EHC
1.77
ENSG
1.61
PNTG
1.41
SEM
1.40
THC
1.38
SGRY
1.34
AIH
1.06
HCA
1.01
Quick Ratio 0.10 6/13 PNTG
42.11
ENSG
30.20
ADUS
28.13
EHC
21.67
FMS
19.71
HCA
14.28
ACHC
13.66
UHS
11.52
SEM
8.65
THC
3.09
SGRY
-1.00
AIH
-1.00
INNV
-1.00
Long Term Debt to Equity 0.70 7/13 THC}
3.33
AIH}
2.37
SEM}
2.23
PNTG}
2.11
SGRY}
1.78
UHS}
0.75
FMS}
0.70
ACHC}
0.60
INNV}
0.37
ENSG}
0.08
EHC}
0.07
ADUS}
0.04
HCA}
-17.54
Debt to Equity 0.82 6/13 AIH
4.28
THC
3.36
SEM
2.38
PNTG
2.23
SGRY
1.83
FMS
0.82
UHS
0.76
ACHC
0.62
INNV
0.42
EHC
0.13
ENSG
0.08
ADUS
0.05
HCA
-19.69
Burn Rate 2.45 3/13 ACHC
3.74
INNV
2.68
FMS
2.45
HCA
2.02
AIH
2.00
SGRY
1.16
SEM
1.02
PNTG
0.35
EHC
-1.18
UHS
-3.41
ENSG
-7.42
ADUS
-14.08
THC
-28.00
Cash to Cap 0.11 3/13 AIH
0.91
THC
0.34
FMS
0.11
ADUS
0.11
INNV
0.09
SEM
0.08
SGRY
0.07
ENSG
0.07
HCA
0.03
ACHC
0.02
UHS
0.01
EHC
0.01
PNTG
0.01
CCR 5.17 2/13 SEM
5.20
FMS
5.17
PNTG
2.93
ADUS
2.31
INNV
1.97
HCA
1.83
THC
1.23
ENSG
1.14
UHS
0.32
ACHC
-0.40
SGRY
-1.42
EHC
AIH
EV to EBITDA 30.16 10/13 INNV}
392.03
PNTG}
205.05
ADUS}
66.62
ENSG}
56.16
THC}
46.48
HCA}
38.23
EHC}
37.65
ACHC}
33.88
UHS}
31.83
FMS}
30.16
SEM}
4.34
AIH}
-38.37
SGRY}
-181.37
EV to Revenue 1.21 8/13 SGRY
2.19
PNTG
1.94
EHC
1.89
ACHC
1.80
HCA
1.79
ENSG
1.68
ADUS
1.67
FMS
1.21
UHS
1.09
THC
0.99
SEM
0.97
AIH
0.96
INNV
0.67